⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11847412 | 0.97 | MAPT (0.38) | — | |
| Hydrochloric Acid SCHEMBL1728561 | 0.97 | — | — | |
| SCHEMBL16005553 | 0.97 | — | — | |
| SCHEMBL22212591 | 0.90 | ALDH1A1 (0.35) | — | |
| SCHEMBL3121478 | 0.88 | GLRA1 (0.39) | — | |
| Hydrochloric Acid SCHEMBL7675204 | 0.85 | HTR2C (0.38) | — | |
| Hydrochloric Acid SCHEMBL7675200 | 0.85 | HTR2C (0.38) | — | |
| SCHEMBL18274688 | 0.85 | ALDH1A1 (0.38) | — | |
| SCHEMBL93781 | 0.83 | — | — | |
| SCHEMBL5496994 | 0.82 | HTR2C (0.45) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2177 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115052882-B | Composition for reducing template penetration into nanopores | 豪夫迈·罗氏有限公司 | 2024-05-24 | — | — | CN | claimed |
| US-20240076718-A1 | CRISPNA FOR GENOME EDITING | UNIVERSIDAD DE GRANADA (ES) | 2024-03-07 | — | — | US | claimed |
| US-20240076274-A1 | TRIAZINE-BASED SELF-ASSEMBLING SYSTEM | COUNCIL SCIENT IND RES (IN) | 2024-03-07 | — | — | US | claimed |
| EP-4284869-A1 | TRIAZINE-BASED SELF-ASSEMBLING SYSTEM | Council of Scientific and Industrial Research (IN) | 2023-12-06 | — | — | EP | claimed |
| EP-4271815-A1 | CRISPNA FOR GENOME EDITING | Universidad de Granada (ES) | 2023-11-08 | — | — | EP | claimed |
| CN-116715828-A | Water-based polyurethane-urea dispersion with enhanced hydrogen bond and ion interaction, and preparation method and application thereof | 万华化学集团股份有限公司 | 2023-09-08 | — | — | CN | claimed |
| CN-116603105-A | Hydroxyapatite carbon fiber material, bone repair biological composite material, preparation method and application | 东华大学 | 2023-08-18 | — | — | CN | claimed |
| CN-113501771-B | Preparation method of N- (2-aminoethyl) glycine derivative | 成都泰和伟业生物科技有限公司 | 2023-07-28 | — | — | CN | claimed |
| CN-111394060-B | Dry-wet dual-purpose anti-fog towel and preparation method thereof | 杭州梵因科技有限公司 | 2022-12-09 | — | — | CN | claimed |
| CN-115052882-A | Compositions for reducing template penetration into nanopores | 豪夫迈·罗氏有限公司 | 2022-09-13 | — | — | CN | claimed |
| US-6033654-A | Bonding together tissue with adhesive containing polyfunctional crosslinking agent and protein polymer | PROTEIN POLYMER TECHNOLGIES, INC. (US) | 2000-03-07 | — | — | US | claimed |
| WO-1999013893-A1 | PEPTIDE NUCLEIC ACIDS HAVING ANTIBACTERIAL ACTIVITY | ISIS PHARMACEUTICALS, INC. (US) | 1999-03-25 | — | — | WO | claimed |
| CN-1189777-A | Tissue Adhesives Utilizing Synthetic Crosslinkers | PROTEIN POLYMER TECH INC (US) | 1998-08-05 | — | — | CN | claimed |
| EP-0823848-A1 | TISSUE ADHESIVE USING SYNTHETIC CROSS-LINKING | PROTEIN POLYMER TECHNOLOGIES, INC. (US) | 1998-02-18 | — | — | EP | claimed |
| WO-1996034618-A1 | TISSUE ADHESIVE USING SYNTHETIC CROSS-LINKING | PROTEIN POLYMER TECHNOLOGIES, INC. (US) | 1996-11-07 | — | — | WO | claimed |
| US-5430133-A | Semi-synthetic glycosaminoglycans with heparin or heparan structure of α-L-iduronic-2-O-sulfate acid modified in position 2 | ALFA WASSERMANN S.P.A. (IT) | 1995-07-04 | — | — | US | claimed |
| US-5410039-A | Process for the synthesis of glycosaminoglycans containing α-L-galacturonic acid substituted with nucleophilic groups in position 3 | ALFA WASSERMANN S.P.A. (IT) | 1995-04-25 | — | — | US | claimed |
| US-5405949-A | Process for the synthesis of glycosaminoglycans with heparin or heparan structure modified in position 2 of the α-L-iduronic-2-O-sulfate acid | ALFA WASSERNANN S.P.A. (IT) | 1995-04-11 | — | — | US | claimed |
| WO-1994001448-A1 | OLIGONUCLEOTIDES MODIFIED WITH CONJUGATE GROUPS | PHARMAGENICS, INC. (US) | 1994-01-20 | — | — | WO | claimed |
| CN-87103752-A | Prepare a kind of monadic method for compositions that suppresses or eliminate | — | 1988-09-21 | — | — | CN | claimed |